메뉴 건너뛰기




Volumn 34, Issue 3, 2003, Pages 348-350

Does Prior Short-Course Nevirapine Reduce the Effectiveness of Subsequent Combination Treatment With Efavirenz? [4]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NEVIRAPINE;

EID: 0242664906     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200311010-00017     Document Type: Letter
Times cited : (3)

References (4)
  • 1
    • 0035913939 scopus 로고    scopus 로고
    • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
    • Eshleman S, Mrachna M, Guay L, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 2001;15:1951-1957.
    • (2001) AIDS , vol.15 , pp. 1951-1957
    • Eshleman, S.1    Mrachna, M.2    Guay, L.3
  • 2
    • 0037099368 scopus 로고    scopus 로고
    • Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type I transmission: A substudy of Pediatric AIDS Clinical Trials Group Protocol 316
    • Cunningham C, Chaix ML, Rekacewiaz C, et al. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type I transmission: a substudy of Pediatric AIDS Clinical Trials Group Protocol 316. J Infect Dis. 2002;186:181-188.
    • (2002) J Infect Dis , vol.186 , pp. 181-188
    • Cunningham, C.1    Chaix, M.L.2    Rekacewiaz, C.3
  • 3
    • 0033179077 scopus 로고    scopus 로고
    • Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: The HIV Outpatient Study (HOPS)
    • Moorman AC, Holmberg SD, Marlowe SI, et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV Outpatient Study (HOPS). Ann Epidemiol. 1999;9:349-357.
    • (1999) Ann Epidemiol , vol.9 , pp. 349-357
    • Moorman, A.C.1    Holmberg, S.D.2    Marlowe, S.I.3
  • 4
    • 0036349478 scopus 로고    scopus 로고
    • Extent and importance of cross-resistance to efavirenz after nevirapine failure
    • Casado JL, Moreno A, Hertogs K, et al. Extent and importance of cross-resistance to efavirenz after nevirapine failure. AIDS Res Hum Retroviruses. 2002;18:771-775.
    • (2002) AIDS Res Hum Retroviruses , vol.18 , pp. 771-775
    • Casado, J.L.1    Moreno, A.2    Hertogs, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.